» Articles » PMID: 19164291

TORC2, a Coactivator of CAMP-response Element-binding Protein, Promotes Epstein-Barr Virus Reactivation from Latency Through Interaction with Viral BZLF1 Protein

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2009 Jan 24
PMID 19164291
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Reactivation of the Epstein-Barr virus from latency is dependent on expression of the viral BZLF1 protein. The BZLF1 promoter (Zp) normally exhibits only low basal activity but is activated in response to chemical inducers such as 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore. We found here that Transducer of Regulated cAMP-response Element-binding Protein (CREB) (TORC) 2 enhances Zp activity 10-fold and more than 100-fold with co-expression of the BZLF1 protein. Mutational analysis of Zp revealed that the activation by TORC is dependent on ZII and ZIII cis elements, binding sites for CREB family transcriptional factors and the BZLF1 protein, respectively. Immunoprecipitation, chromatin immunoprecipitation, and reporter assay using Gal4-luc and Gal4BD-BZLF1 fusion protein indicate that TORC2 interacts with BZLF1, and that the complex is efficiently recruited onto Zp. These observations clearly indicate that TORC2 activates the promoter through interaction with the BZLF1 protein as well as CREB family transcriptional factors. Induction of the lytic replication resulted in the translocation of TORC2 from cytoplasm to viral replication compartments in nuclei, and furthermore, activation of Zp by TORC2 was augmented by calcium-regulated phosphatase, calcineurin. Silencing of endogenous TORC2 gene expression by RNA interference decreased the levels of the BZLF1 protein in response to 12-O-tetradecanoylphorbol-13-acetate/ionophore. Based on these results, we conclude that Epstein-Barr virus exploits the calcineurin-TORC signaling pathway through interactions between TORC and the BZLF1 protein in reactivation from latency.

Citing Articles

Identifying the key regulators orchestrating Epstein-Barr virus reactivation.

Wang Y, Yu J, Pei Y Front Microbiol. 2024; 15:1505191.

PMID: 39703703 PMC: 11655498. DOI: 10.3389/fmicb.2024.1505191.


CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway.

Li Y, Zhang Y, Shi H, Liu X, Li Z, Zhang J Mol Med. 2023; 29(1):146.

PMID: 37884902 PMC: 10604535. DOI: 10.1186/s10020-023-00744-0.


Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1.

De La Cruz-Herrera C, Tatham M, Siddiqi U, Shire K, Marcon E, Greenblatt J PLoS Pathog. 2023; 19(7):e1011477.

PMID: 37410772 PMC: 10353822. DOI: 10.1371/journal.ppat.1011477.


EBV Exploits RNA mA Modification to Promote Cell Survival and Progeny Virus Production During Lytic Cycle.

Yanagi Y, Watanabe T, Hara Y, Sato Y, Kimura H, Murata T Front Microbiol. 2022; 13:870816.

PMID: 35783391 PMC: 9240777. DOI: 10.3389/fmicb.2022.870816.


Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma.

Dochi H, Kondo S, Murata T, Fukuyo M, Nanbo A, Wakae K Cancer Sci. 2022; 113(8):2862-2877.

PMID: 35633182 PMC: 9357606. DOI: 10.1111/cas.15440.


References
1.
Xu W, Kasper L, Lerach S, Jeevan T, Brindle P . Individual CREB-target genes dictate usage of distinct cAMP-responsive coactivation mechanisms. EMBO J. 2007; 26(12):2890-903. PMC: 1894772. DOI: 10.1038/sj.emboj.7601734. View

2.
Flemington E, Speck S . Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. 1990; 64(3):1227-32. PMC: 249237. DOI: 10.1128/JVI.64.3.1227-1232.1990. View

3.
Kudoh A, Fujita M, Kiyono T, Kuzushima K, Sugaya Y, Izuta S . Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol. 2002; 77(2):851-61. PMC: 140784. DOI: 10.1128/jvi.77.2.851-861.2003. View

4.
Liu S, Liu P, Borras A, Chatila T, Speck S . Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member. EMBO J. 1997; 16(1):143-53. PMC: 1169621. DOI: 10.1093/emboj/16.1.143. View

5.
Taylor N, Flemington E, Kolman J, Baumann R, Speck S, Miller G . ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter. J Virol. 1991; 65(8):4033-41. PMC: 248834. DOI: 10.1128/JVI.65.8.4033-4041.1991. View